Literature DB >> 14707127

Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles.

Satoru Noguchi1, Yoko Keira, Kumiko Murayama, Megumu Ogawa, Masako Fujita, Genri Kawahara, Yasushi Oya, Masaoki Imazawa, Yu-Ichi Goto, Yukiko K Hayashi, Ikuya Nonaka, Ichizo Nishino.   

Abstract

Distal myopathy with rimmed vacuoles is an autosomal recessive muscle disease with preferential involvement of the tibialis anterior that spares the quadriceps muscles in young adulthood. In a Japanese patient with distal myopathy with rimmed vacuoles, we identified pathogenic mutations in the gene encoding the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase, which catalyzes the initial two steps in the biosynthesis of sialic acid. In this study, we demonstrated the relationship between the genetic mutations and enzymatic activities using an in vitro expression assay system. Furthermore, we also showed that the levels of sialic acid in muscle and primary cultured cells from DMRV patients were reduced to 60-75% of control. The reactivities to lectins were also variable in some myofibers, suggesting that hyposialylation and abnormal glycosylation in muscles may contribute to the focal accumulations of autophagic vacuoles, amyloid deposits, or both in patient muscle tissue. The addition of ManNAc and NeuAc to primary cultured cells normalized sialylation levels, thus demonstrating the therapeutic potential of these compounds for this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707127     DOI: 10.1074/jbc.M313171200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Clinical features, lectin staining, and a novel GNE frameshift mutation in hereditary inclusion body myopathy.

Authors:  N C Voermans; M Guillard; R Doedée; M Lammens; M Huizing; G W Padberg; R A Wevers; B G van Engelen; D J Lefeber
Journal:  Clin Neuropathol       Date:  2010 Mar-Apr       Impact factor: 1.368

2.  Mutation analysis of the GNE gene in Korean patients with distal myopathy with rimmed vacuoles.

Authors:  Byoung Joon Kim; Chang-Seok Ki; Jong-Won Kim; Duk Hyun Sung; Young-Chul Choi; Seung Hyun Kim
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

3.  Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy.

Authors:  Anna Cho; May Christine; V Malicdan; Miho Miyakawa; Ikuya Nonaka; Ichizo Nishino; Satoru Noguchi
Journal:  Hum Mol Genet       Date:  2017-08-15       Impact factor: 6.150

4.  Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.

Authors:  Takahiro Yonekawa; May Christine V Malicdan; Anna Cho; Yukiko K Hayashi; Ikuya Nonaka; Toshiki Mine; Takeshi Yamamoto; Ichizo Nishino; Satoru Noguchi
Journal:  Brain       Date:  2014-07-24       Impact factor: 13.501

5.  Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy.

Authors:  Petcharat Leoyklang; May Christine Malicdan; Tal Yardeni; Frank Celeste; Carla Ciccone; Xueli Li; Rong Jiang; William A Gahl; Nuria Carrillo-Carrasco; Miao He; Marjan Huizing
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

6.  Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins.

Authors:  Youichi Tajima; Eiichiro Uyama; Shinji Go; Chihiro Sato; Nodoka Tao; Masaharu Kotani; Hirotake Hino; Akemi Suzuki; Yutaka Sanai; Ken Kitajima; Hitoshi Sakuraba
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model.

Authors:  May Christine V Malicdan; Satoru Noguchi; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

8.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

9.  Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.

Authors:  Anagha P Phadke; Chris Jay; Salina J Chen; Courtney Haddock; Zhaohui Wang; Yang Yu; Derek Nemunaitis; Gregory Nemunaitis; Nancy S Templeton; Neil Senzer; Phillip B Maples; Alex W Tong; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-05-08

10.  Hereditary Inclusion Body Myopathy (HIBM2).

Authors:  Chris M Jay; Nick Levonyak; Gregory Nemunaitis; Phillip B Maples; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.